Oncology

Top news of the week in cancer research.

Using precision medicine, researchers were able to slow down the amount of time it takes for a tumor to grow back in patients with advanced cancer.

Tumor cells grown in mice first could potentially change the cancer research landscape.

Patients risk the development of thyroid dysfunction from interferon alpha in patients with hepatitis C virus infection.

The largest study to examine the relationship between anxiety and cancer death sheds light on the importance of taking anxiety seriously.

Pevonedistat shows potential to stop melanoma and other types of cancer.

Ultrasound not deemed to be sufficiently sensitive to detect early stage liver cancer.

New research highlights the need for earlier access to effective pain medications among advanced cancer patients.

Top news of the day from across the healthcare landscape.

Combination treatment with chemotherapy shows significant survival advantage over chemotherapy alone in pancreatic cancer.

Analysis compares endosonography with mediastinoscopy in non-small cell lung cancer.

Environmental exposure to common chemicals found to inhibit tamoxifen efficacy in breast cancer patients.

Top news of the week in oncology, and cancer drug development.

Stiffness and hypoxia environments triggers the spread of breast cancer.

Researchers mimic the genetic mechanisms that block the development of Ras-dependent cancers.

Sunscreen can decrease the risk of melanoma by more than 30%.

Injection drug users carry a different set of challenges during treatment for hepatitis C virus.

Non-invasive liquid biopsies may be more a more effective alternative to tissue biopsies in patients with advanced lung cancer.

Top news of the day from across the health care landscape.

Pevonedistat, currently being tested in clinical trials, shows promise in killing melanomas and other cancer types.

Experimental combination therapy shows a significant survival advantage over chemotherapy alone in pancreatic cancer.

National Health Checkup finds that cancer beat out infectious diseases as the biggest concern.

Top news of the day from across the health care landscape.

New insights pave the way for future treatment developments of pancreatic ductal adenocarcinoma.

Although these interactions pose a threat to patients, pharmacists can play a large role in minimizing them.

Top news of the week in oncology, and cancer drug development.

New mouse study suggests that exposure to endocrine disrupting chemicals may cause resistance to tamoxifen therapy in some breast cancers.

Novel drug combined with gemcitabine chemotherapy shows promise